Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/78180
Type: Artigo de Periódico
Title: Androgen receptor in salivary gland carcinoma: a review of an old marker as a possible new target
Authors: Chit Cheng Yeoh
Nedal Dabab
Elyse Rigby
Ritu Chhikara
Iolia Akaev
Ricardo Santiago Gomez
Felipe Paiva Fonseca
Peter Brennan
Siavash Rahimi
Abstract: The role of the androgen receptor (AR) as an immunomarker for diagnosis of salivary gland duct carcinoma (SDC) is well known. Other non-squamous cell head and neck cancers (NSCC-HN), including a small subset of salivary gland cancers (SGCs), can also express AR. With the increase in effective and powerful new generation of anti-androgen agents and drugs administered orally, more targetable AR-driven NSCC-HN, such as subsets of SGCs, should be investigated for possible expression of AR. In this review, we focus on SGC subtypes, which could express AR and describe the main androgen deprivation therapy (ADT) strategies.
Subject: Abiraterone acetate
Receptors, androgen
Immunohistochemistry
Carcinoma, mucoepidermoid
Carcinoma, adenoid cystic
Adenocarcinoma
Prognosis
Radiotherapy
Excision repair
Androgen antagonists
Drug therapy
language: eng
metadata.dc.publisher.country: Brasil
Publisher: Universidade Federal de Minas Gerais
Publisher Initials: UFMG
metadata.dc.publisher.department: FAO - DEPARTAMENTO DE CLÍNICA
Rights: Acesso Aberto
metadata.dc.identifier.doi: https://doi.org/10.1111/jop.12741
URI: http://hdl.handle.net/1843/78180
Issue Date: 2018
metadata.dc.url.externa: https://onlinelibrary.wiley.com/doi/10.1111/jop.12741
metadata.dc.relation.ispartof: Journal of Oral Pathology & Medicine
Appears in Collections:Artigo de Periódico



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.